ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Erasca (ERAS) To Contact Him Directly To Discuss Their Options

If you purchased or acquired stock in Erasca and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.

Click here to participate in the action.

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) --

What’s Happening:

  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) on behalf of Erasca stockholders. Our investigation concerns whether Erasca has violated the federal securities laws and/or engaged in other unlawful business practices.

Investigation Details:

  • On April 28, 2026, Erasca disclosed that it had received a letter from Revolution Medicines alleging that Erasca’s ERAS-0015—a Phase 1 oral pan-RAS molecular glue inhibitor designed to target cancers—infringes a Revolution patent and is associated with alleged trade secret misappropriation. Following this disclosure, Erasca’s share price declined by $9.25 per share, or approximately 48%, falling from $19.15 per share on April 27, 2026 to close at $9.90 per share on April 28, 2026.

Next Steps:

  • If you purchased or otherwise acquired Erasca shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com.  Attorney advertising.  Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.22
-2.91 (-1.08%)
AAPL  298.21
-0.66 (-0.22%)
AMD  449.70
+4.20 (0.94%)
BAC  49.85
+0.01 (0.02%)
GOOG  397.17
-1.87 (-0.47%)
META  618.43
+1.80 (0.29%)
MSFT  409.43
+4.22 (1.04%)
NVDA  235.74
+9.91 (4.39%)
ORCL  195.61
+5.85 (3.08%)
TSLA  443.30
-1.97 (-0.44%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.